BrightFocus Foundation
July 29, 2026
BrightFocus Foundation’s Macular Degeneration Research program is fueling the most promising scientific studies around the world to advance prevention, earlier detection, treatments, and ultimately a cure for macular degeneration. This year alone, we’ve invested $4.7 million in new funding for bold, forward-thinking research. In this session, learn about some of these pioneering projects and explore the exciting ideas shaping the future of vision research.
Macular Chats are free audio conversations with leading vision specialists and eye care experts. Learn about the latest in research, treatment options, and practical tips for daily living with macular degeneration.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $330 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
Mathew MacCumber, MD, PhD, explains how clinical trials work, the potential benefits and challenges of participation, and key factors to consider when deciding whether a trial may be right for you.
In this episode, we explain how these therapies are intended to work, how the cells may be delivered to the eye, and the potential risks.
In this interactive episode, Dr. Joshua Dunaief answers listener questions about macular degeneration.
Manuel Amador, MD, explains today’s wet AMD treatments and why consistency matters.
Help Fight Macular Degeneration and Save Sight
Your donation helps fund critical research to bring us closer to a cure for this sight-stealing disease and provide vital information to the public.
Donate Today
